Site Search

Biomarker testing helps connect patients with the right treatment at the right time. ACS CAN Iowa & Partners Support  SSB 3001   This bill would increase access to biomarker testing, which is a necessary first step to accessing precision medicine.  Precision medicine includes targeted therapies that can lead to improved survivorship and better quality of life for cancer patients. Timely access to guideline-indicated comprehensive biomarker testing will enable more patients to access the most effective treatments for their disease and can potentially help achieve the triple aim of health care: better health outcomes, improved quality of life and reduced costs.  This legislation will ensure Iowans covered by Medicaid and ...